JP2016196511A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016196511A5 JP2016196511A5 JP2016163544A JP2016163544A JP2016196511A5 JP 2016196511 A5 JP2016196511 A5 JP 2016196511A5 JP 2016163544 A JP2016163544 A JP 2016163544A JP 2016163544 A JP2016163544 A JP 2016163544A JP 2016196511 A5 JP2016196511 A5 JP 2016196511A5
- Authority
- JP
- Japan
- Prior art keywords
- dosage form
- pharmaceutical dosage
- phenylephrine
- ketorolac
- buffer system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261718026P | 2012-10-24 | 2012-10-24 | |
| US61/718,026 | 2012-10-24 | ||
| US201261736179P | 2012-12-12 | 2012-12-12 | |
| US61/736,179 | 2012-12-12 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015539749A Division JP6017053B2 (ja) | 2012-10-24 | 2013-10-23 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016208082A Division JP2017014294A (ja) | 2012-10-24 | 2016-10-24 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2018002514A Division JP2018058905A (ja) | 2012-10-24 | 2018-01-11 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016196511A JP2016196511A (ja) | 2016-11-24 |
| JP2016196511A5 true JP2016196511A5 (enExample) | 2017-01-05 |
| JP6282699B2 JP6282699B2 (ja) | 2018-02-21 |
Family
ID=50545210
Family Applications (8)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015539749A Active JP6017053B2 (ja) | 2012-10-24 | 2013-10-23 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2016163544A Active JP6282699B2 (ja) | 2012-10-24 | 2016-08-24 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2016208082A Pending JP2017014294A (ja) | 2012-10-24 | 2016-10-24 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2018002514A Withdrawn JP2018058905A (ja) | 2012-10-24 | 2018-01-11 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2019036146A Withdrawn JP2019081798A (ja) | 2012-10-24 | 2019-02-28 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2020104619A Withdrawn JP2020147606A (ja) | 2012-10-24 | 2020-06-17 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2023012804A Withdrawn JP2023041804A (ja) | 2012-10-24 | 2023-01-31 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2024207997A Pending JP2025019330A (ja) | 2012-10-24 | 2024-11-29 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015539749A Active JP6017053B2 (ja) | 2012-10-24 | 2013-10-23 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
Family Applications After (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016208082A Pending JP2017014294A (ja) | 2012-10-24 | 2016-10-24 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2018002514A Withdrawn JP2018058905A (ja) | 2012-10-24 | 2018-01-11 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2019036146A Withdrawn JP2019081798A (ja) | 2012-10-24 | 2019-02-28 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2020104619A Withdrawn JP2020147606A (ja) | 2012-10-24 | 2020-06-17 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2023012804A Withdrawn JP2023041804A (ja) | 2012-10-24 | 2023-01-31 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
| JP2024207997A Pending JP2025019330A (ja) | 2012-10-24 | 2024-11-29 | 安定で保存剤非含有の散瞳および抗炎症注射用液剤 |
Country Status (39)
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2397574T3 (es) | 2002-07-30 | 2013-03-08 | Omeros Corporation | Procedimiento y soluciones de irrigación oftalmológica |
| AU2013201465B2 (en) * | 2012-10-24 | 2016-03-03 | Rayner Intraocular Lenses Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
| US20210346318A1 (en) * | 2013-10-03 | 2021-11-11 | Harrow Ip, Llc | Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof |
| US10993921B2 (en) * | 2013-10-03 | 2021-05-04 | Harrow Ip, Llc | Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof |
| TWI809304B (zh) * | 2014-12-01 | 2023-07-21 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
| CN104856990A (zh) * | 2015-05-07 | 2015-08-26 | 武汉武药科技有限公司 | 去氧肾上腺素酮咯酸溶液及制备方法 |
| US11213480B1 (en) * | 2015-08-06 | 2022-01-04 | Hikma Pharmaceuticals International Limited | Phenylephrine hydrochloride ready-to-use solution |
| USD831868S1 (en) | 2015-09-17 | 2018-10-23 | Lume Cube, Inc. | Compact external light |
| US10704745B2 (en) | 2015-10-13 | 2020-07-07 | Lume Cube, Inc. | Mobile light source |
| WO2018039420A1 (en) | 2016-08-25 | 2018-03-01 | Imprimis Pharmaceuticals, Inc. | Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof |
| US20180318319A1 (en) * | 2017-05-04 | 2018-11-08 | Ocular Science, Inc. | Compositions and Methods for Treating Eyes and Methods of Preparation |
| JP7078843B2 (ja) * | 2018-03-26 | 2022-06-01 | サミー株式会社 | 遊技機 |
| EP3870170A4 (en) * | 2018-10-26 | 2022-07-20 | Ocuphire Pharma, Inc. | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PRESBYOPIA, MYDRIASIS AND OTHER EYE DISEASES |
| US11071724B2 (en) | 2019-05-17 | 2021-07-27 | Ocular Science, Inc. | Compositions and methods for treating presbyopia |
| DE102019125430B3 (de) | 2019-09-20 | 2020-11-19 | Carl Zeiss Meditec Ag | Steuerungsvorrichtung für ein ophthalmochirurgisches System, ophthalmochirurgisches System sowie Computerprogrammprodukt |
| KR102749980B1 (ko) | 2020-01-02 | 2025-01-03 | 삼성전자주식회사 | 에어 스페이서를 가지는 반도체 소자 |
| WO2021150747A1 (en) * | 2020-01-22 | 2021-07-29 | Nevakar Inc. | Phenylephrine hydrochloride compositions and containers |
| EP4262809A4 (en) * | 2020-12-17 | 2024-10-23 | Harrow IP, LLC | MYDRIATIC COMPOSITIONS AND METHODS OF MANUFACTURE THEREOF |
| CN115368310B (zh) | 2021-05-18 | 2025-06-27 | 奥库菲尔医药公司 | 合成甲磺酸酚妥拉明的方法 |
| US12029729B2 (en) | 2021-07-23 | 2024-07-09 | Somerset Therapeutics, Llc | Chelated, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof |
| US11696910B2 (en) | 2021-07-23 | 2023-07-11 | Somerset Therapeutics, Llc | Buffer-free, stable ophthalmological compositions of ketorolac and phenylephrine and applications thereof |
| WO2024086268A1 (en) * | 2022-10-19 | 2024-04-25 | Fresenius Kabi Austria Gmbh | Phenylephrine liquid formulations |
| CN115950992B (zh) * | 2023-03-15 | 2023-06-09 | 苏州朗易生物医药研究有限公司 | 一种去氧肾上腺素酮咯酸溶液中有关物质的检测方法及其应用 |
| WO2025165753A1 (en) * | 2024-01-31 | 2025-08-07 | Hikma Pharmaceuticals Usa Inc. | Pharmaceutical formulations of phenylephrine and process of making the same |
Family Cites Families (94)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4402949A (en) | 1979-11-12 | 1983-09-06 | Sandoz Ltd. | Stable solutions of hydrogenated ergotalkaloids |
| US4550022A (en) | 1981-10-05 | 1985-10-29 | Alcon Laboratories, Inc. | Tissue irrigating solution |
| JPS58126810A (ja) | 1981-12-24 | 1983-07-28 | Kaken Pharmaceut Co Ltd | 抗炎症眼科用液剤およびその製法 |
| US4474751A (en) | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
| JPS6017053U (ja) | 1983-07-11 | 1985-02-05 | 住友電気工業株式会社 | 伝送エラ−検出器 |
| WO1987007141A1 (en) | 1986-05-23 | 1987-12-03 | New England Medical Center Hospitals, Inc. | Method for treating glaucoma |
| US5212196A (en) | 1986-10-21 | 1993-05-18 | Alcon Laboratories, Inc. | Control of post-surgical intraocular pressure using clonidine derivatives |
| US4938970A (en) | 1987-02-06 | 1990-07-03 | Hustead Robert E | Painless electrolyte solutions |
| US5110493A (en) | 1987-09-11 | 1992-05-05 | Syntex (U.S.A.) Inc. | Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant |
| US4876250A (en) | 1988-10-31 | 1989-10-24 | Alcon Laboratories, Inc. | Methods for controlling ocular hypertension with angiostatic steroids |
| DE3833893A1 (de) | 1988-10-05 | 1990-04-12 | Bayer Ag | Verwendung von basischen nitro-phenyl-dihydropyridin-amiden als arzneimittel, neue verbindungen und verfahren zu ihrer herstellung ueber neue zwischenprodukte |
| US5036046A (en) | 1988-10-12 | 1991-07-30 | Eye Research Institute Of Retina Foundation, Inc. | Method for enhancing healing of corneal endothelial wounds |
| US5051443A (en) | 1988-10-12 | 1991-09-24 | Eye Research Institute Of Retina Foundation, Inc. | Method for enhancing healing of corneal endothelial wounds |
| US5371078A (en) | 1988-10-31 | 1994-12-06 | Alcon Laboratories, Inc. | Angiostatic steroids and methods and compositions for controlling ocular hypertension |
| US5116868A (en) | 1989-05-03 | 1992-05-26 | The Johns Hopkins University | Effective ophthalmic irrigation solution |
| WO1991002527A1 (en) | 1989-08-21 | 1991-03-07 | Beth Israel Hospital Association | Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists |
| US5679650A (en) * | 1993-11-24 | 1997-10-21 | Fukunaga; Atsuo F. | Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine |
| EP0502143B1 (en) | 1990-09-07 | 1995-11-08 | Universidad De Alicante | Composition for treating ocular pain |
| US5318780A (en) | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
| IT1252692B (it) | 1991-11-27 | 1995-06-23 | Zambon Spa | Composizione farmaceutica per uso oftalmico contenente un antiinfiammatorio non steroideo ed un decongestionante come principi attivi |
| AU5405894A (en) * | 1992-10-21 | 1994-05-09 | Alcon Laboratories, Inc. | Composition for irrigating intraocular tissues and maintaining mydriasis during intraocular surgery |
| US6117907A (en) | 1993-04-14 | 2000-09-12 | Sher; Neal A. | Topical treatment of ocular pain after corneal surgery |
| EP0670733A1 (en) | 1993-09-29 | 1995-09-13 | Alcon Laboratories, Inc. | Compositions containing growth factors and antiplastic agents |
| CA2149528A1 (en) | 1993-09-29 | 1995-04-06 | Billie M. York | Compositions containing growth factors and antimetabolites |
| US5624893A (en) | 1993-10-14 | 1997-04-29 | Alcon Laboratories, Inc. | Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation |
| EP0734248A1 (en) | 1993-12-17 | 1996-10-02 | Alcon Laboratories, Inc. | Improved intraocular irrigating solution containing non-steroidal antiinflammatory agent |
| US6350781B1 (en) | 1994-01-14 | 2002-02-26 | Lee Shahinia, Jr. | Method and analgesic preparations for sustained and extended corneal analgesia with subanesthetic concentrations of lidocaine |
| WO1995034298A1 (en) | 1994-06-10 | 1995-12-21 | Telor Ophthalmic Pharmaceuticals, Inc. | Inhibition of intraoperative miosis/production of mydriasis by local anesthetics |
| US5523316A (en) | 1994-06-23 | 1996-06-04 | Alcon Laboratories, Inc. | Intraocular irrigating solution containing agent for controlling IOP |
| WO2000023066A2 (en) | 1998-10-20 | 2000-04-27 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain and inflammation |
| US7091181B2 (en) | 1994-12-12 | 2006-08-15 | Omeros Corporation | Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors |
| AU4467396A (en) | 1994-12-12 | 1996-07-10 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain, inflammation and spasm |
| KR100517210B1 (ko) | 1994-12-12 | 2006-06-07 | 오메로스 코포레이션 | 통증,염증및경련억제용관주용액 |
| WO2000023072A1 (en) | 1998-10-20 | 2000-04-27 | Omeros Medical Systems, Inc. | Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation |
| EP0799051B1 (en) | 1994-12-12 | 2005-07-27 | Omeros Corporation | Irrigation solution and use thereof for perioperatively inhibiting pain, inflammation and spasm at a wound |
| US6492332B1 (en) | 1995-12-12 | 2002-12-10 | Omeros Corporation | Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation |
| US5972326A (en) | 1995-04-18 | 1999-10-26 | Galin; Miles A. | Controlled release of pharmaceuticals in the anterior chamber of the eye |
| US5612027A (en) | 1995-04-18 | 1997-03-18 | Galin; Miles A. | Controlled release of miotic and mydriatic drugs in the anterior chamber |
| US5767105A (en) | 1995-05-03 | 1998-06-16 | Peyman; Gholam A. | Ocular solution |
| US5798356A (en) | 1995-08-07 | 1998-08-25 | Alcon Laboratories, Inc. | Angiostatic compounds |
| US5849761A (en) | 1995-09-12 | 1998-12-15 | Regents Of The University Of California | Peripherally active anti-hyperalgesic opiates |
| US6413961B1 (en) | 1995-12-12 | 2002-07-02 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain and inflammation |
| US6280745B1 (en) | 1997-12-23 | 2001-08-28 | Alliance Pharmaceutical Corp. | Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| WO1998004171A1 (en) | 1996-07-26 | 1998-02-05 | Schein Dental Equipment Co. | Armrest mechanism for dental chairs |
| GB9704352D0 (en) | 1997-03-03 | 1997-04-23 | Chiroscience Ltd | Levobupivacaine and its use |
| US6030974A (en) | 1997-04-02 | 2000-02-29 | The Regents Of The University Of California | Method of anesthesia |
| US5811446A (en) | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| US6034256A (en) | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
| US6495598B1 (en) | 1997-04-22 | 2002-12-17 | Ophtecs Corporation | Perfusate preparation for ophthalmic operation |
| EP0903151A1 (en) | 1997-09-22 | 1999-03-24 | ASTA Medica Aktiengesellschaft | Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms |
| US6495529B1 (en) | 1998-07-01 | 2002-12-17 | Warner-Lambert Company | (−)-Pseudoephedrine as a sympathomimetic drug |
| CN1114401C (zh) | 1998-07-14 | 2003-07-16 | 阿尔康实验室公司 | 11－(3－二甲氨基亚丙基)－6,11－二氢二苯并[b,e]噁庚英－2－乙酸用于制药的新用途 |
| US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| FR2782721B1 (fr) | 1998-09-01 | 2000-11-03 | Inst Nat Sante Rech Med | Nouveaux composes phosphohalohydrines, procede de fabrication et applications |
| US6395746B1 (en) | 1998-09-30 | 2002-05-28 | Alcon Manufacturing, Ltd. | Methods of treating ophthalmic, otic and nasal infections and attendant inflammation |
| AU1214900A (en) | 1998-10-20 | 2000-05-08 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain and inflammation |
| US7973068B2 (en) | 1998-10-20 | 2011-07-05 | Omeros Corporation | Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
| US20030087962A1 (en) | 1998-10-20 | 2003-05-08 | Omeros Corporation | Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation |
| AU1214800A (en) | 1998-10-21 | 2000-05-08 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain and inflammation |
| AU1345000A (en) | 1998-11-05 | 2000-05-22 | Omeros Medical Systems, Inc. | Irrigation solution and method for inhibition of pain and inflammation |
| US6433007B1 (en) | 1998-12-17 | 2002-08-13 | Alcon Manufacturing, Ltd. | Methods for the prevention and treatment of post-surgical complications |
| WO2000051620A1 (en) * | 1999-03-02 | 2000-09-08 | Vitreo-Retinal Technologies, Inc. | Agents for intravitreal administration to treat or prevent disorders of the eye |
| AU5010800A (en) | 1999-05-14 | 2000-12-05 | Regents Of The University Of California, The | Anti-inflammatory therapy for inflammatory mediated infection |
| AU5286901A (en) | 1999-10-22 | 2001-06-18 | Transdermatech, Inc. | Topical anesthetic formulation |
| US6218428B1 (en) | 2000-04-28 | 2001-04-17 | Emil Chynn | Ophthalmic composition |
| AU2001257326A1 (en) | 2000-04-28 | 2001-11-12 | Memorial Sloan-Kettering Cancer Center | Topical anesthetic/opioid formulations and uses thereof |
| US20020128267A1 (en) | 2000-07-13 | 2002-09-12 | Rebanta Bandyopadhyay | Method of using COX-2 inhibitors in the treatment and prevention of ocular COX-2 mediated disorders |
| PE20020146A1 (es) | 2000-07-13 | 2002-03-31 | Upjohn Co | Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2) |
| EP1301210A2 (en) | 2000-07-14 | 2003-04-16 | Allergan, Inc. | Compositions containing therapeutically active components having enhanced solubility |
| AR035651A1 (es) | 2000-07-28 | 2004-06-23 | Univ Madrid Complutense | Uso de derivados de indol para la manufactura de un medicamento para reducir la presion intraocular y una composicion |
| JP2002161032A (ja) | 2000-09-14 | 2002-06-04 | Taisho Pharmaceut Co Ltd | 粘膜適用組成物 |
| WO2002024191A1 (fr) | 2000-09-20 | 2002-03-28 | Yong Guang Pharmaceutical Co., Ltd. | Medicament permettant de traiter et de prevenir la myopie |
| US20020183279A1 (en) | 2001-04-18 | 2002-12-05 | Koichiro Tanaka | Pharmaceutical composition containing viscoelastic substance and medication |
| US20020198209A1 (en) | 2001-05-03 | 2002-12-26 | Allergan Sales Inc. | Compositions having enhanced pharmacokinetic characteristics |
| US20030191187A1 (en) | 2002-04-01 | 2003-10-09 | Lee Fang Yu | Injectable pharmaceutical composition containing a non-steroidal anti-inflammatory drug and method for preparing the same |
| ES2397574T3 (es) * | 2002-07-30 | 2013-03-08 | Omeros Corporation | Procedimiento y soluciones de irrigación oftalmológica |
| US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| JP4950063B2 (ja) * | 2004-12-22 | 2012-06-13 | シェーリング コーポレイション | 薬学的製剤 |
| JP4966204B2 (ja) | 2004-12-23 | 2012-07-04 | ロックスロ ファーマ， インコーポレイテッド | ケトロラクの鼻腔内投与のための治療用組成物 |
| FR2882930B1 (fr) | 2005-03-09 | 2009-03-27 | Walid Katib | Nouvelles compositions ophtalmologiques et leur mode d'utilisation |
| DOP2007000055A (es) * | 2006-04-10 | 2007-10-31 | Senosiain S A De C V Lab | Composición farmaceutica que comprende un analgésico y vitaminas |
| US20090258850A1 (en) | 2007-08-21 | 2009-10-15 | Frincke James M | Stabilized therapeutic compositions and formulations |
| MX2010005012A (es) | 2007-11-08 | 2010-06-23 | Aciex Therapeutics Inc | Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor. |
| RU2600863C2 (ru) | 2007-12-10 | 2016-10-27 | Сентисс Фарма Прайвит Лимитед | Офтальмическая композиция, включающая фенилэфрин |
| US7842714B2 (en) | 2008-03-03 | 2010-11-30 | Allergan, Inc. | Ketorolac tromethamine compositions for treating ocular pain |
| US9192571B2 (en) | 2008-03-03 | 2015-11-24 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
| RU2011140486A (ru) * | 2009-03-06 | 2013-04-20 | МЕДИММЬЮН, ЭлЭлСи | Композиции, содержащие гуманизированные антитела к cd19 |
| US8277781B2 (en) | 2009-03-13 | 2012-10-02 | Luitpold Pharmaceuticals, Inc. | Device for intranasal administration |
| EP2437743A4 (en) * | 2009-06-05 | 2012-11-28 | Aciex Therapeutics Inc | OPHTHALMIC FORMULATIONS OF FLUTICASONE AND METHODS OF USE |
| CA2764477A1 (en) | 2009-06-05 | 2010-12-09 | Aciex Therapeutics, Inc. | Ophthalmic formulations, methods of manufacture, and methods of using same |
| US8680510B2 (en) | 2010-06-28 | 2014-03-25 | International Business Machines Corporation | Method of forming compound semiconductor |
| EP3434257A1 (en) | 2010-07-29 | 2019-01-30 | Allergan, Inc. | Preservative free brimonidine and timolol solutions |
| AU2013201465B2 (en) * | 2012-10-24 | 2016-03-03 | Rayner Intraocular Lenses Limited | Stable preservative-free mydriatic and anti-inflammatory solutions for injection |
| TWI809304B (zh) | 2014-12-01 | 2023-07-21 | 奥默羅斯公司 | 用於抑制術後眼睛炎性病況的抗炎和散瞳前房溶液 |
-
2013
- 2013-03-07 AU AU2013201465A patent/AU2013201465B2/en active Active
- 2013-10-23 PT PT138483821T patent/PT2911511T/pt unknown
- 2013-10-23 UA UAA201505028A patent/UA114650C2/uk unknown
- 2013-10-23 KR KR1020177033129A patent/KR20170128640A/ko not_active Ceased
- 2013-10-23 EA EA201590807A patent/EA033811B1/ru unknown
- 2013-10-23 MY MYPI2015001038A patent/MY188474A/en unknown
- 2013-10-23 PE PE2015000544A patent/PE20150958A1/es unknown
- 2013-10-23 GE GEAP201313833A patent/GEP20186891B/en unknown
- 2013-10-23 SM SM20210393T patent/SMT202100393T1/it unknown
- 2013-10-23 KR KR1020157012282A patent/KR101808394B1/ko active Active
- 2013-10-23 NZ NZ628398A patent/NZ628398A/en unknown
- 2013-10-23 IL IL238439A patent/IL238439B2/en unknown
- 2013-10-23 EP EP21167904.8A patent/EP3909572B1/en active Active
- 2013-10-23 HR HRP20210980TT patent/HRP20210980T1/hr unknown
- 2013-10-23 WO PCT/US2013/066349 patent/WO2014066485A1/en not_active Ceased
- 2013-10-23 SG SG11201502602WA patent/SG11201502602WA/en unknown
- 2013-10-23 IN IN3029DEN2015 patent/IN2015DN03029A/en unknown
- 2013-10-23 CA CA2887772A patent/CA2887772C/en active Active
- 2013-10-23 AP AP2015008459A patent/AP2015008459A0/xx unknown
- 2013-10-23 MD MDA20150050A patent/MD20150050A2/ro not_active Application Discontinuation
- 2013-10-23 US US14/061,039 patent/US9066856B2/en active Active
- 2013-10-23 LT LTEP13848382.1T patent/LT2911511T/lt unknown
- 2013-10-23 CN CN201380055290.3A patent/CN104822265A/zh active Pending
- 2013-10-23 CN CN201810548093.XA patent/CN108721210A/zh active Pending
- 2013-10-23 AR ARP130103855A patent/AR093115A1/es not_active Application Discontinuation
- 2013-10-23 SI SI201331903T patent/SI2911511T1/sl unknown
- 2013-10-23 MX MX2015005089A patent/MX382411B/es unknown
- 2013-10-23 JP JP2015539749A patent/JP6017053B2/ja active Active
- 2013-10-23 ES ES21167904T patent/ES3040229T3/es active Active
- 2013-10-23 RS RS20210878A patent/RS62188B1/sr unknown
- 2013-10-23 KR KR1020197038220A patent/KR102211784B1/ko active Active
- 2013-10-23 ES ES13848382T patent/ES2875432T3/es active Active
- 2013-10-23 EP EP13848382.1A patent/EP2911511B1/en active Active
- 2013-10-23 KR KR1020217002992A patent/KR102496463B1/ko active Active
- 2013-10-23 PL PL13848382T patent/PL2911511T3/pl unknown
- 2013-10-23 DK DK13848382.1T patent/DK2911511T3/da active
- 2013-10-23 HU HUE13848382A patent/HUE055537T2/hu unknown
- 2013-10-23 BR BR112015009228-4A patent/BR112015009228B1/pt active IP Right Grant
- 2013-10-23 MX MX2020012591A patent/MX2020012591A/es unknown
- 2013-10-23 MY MYPI2020001054A patent/MY204103A/en unknown
- 2013-10-23 MA MA38096A patent/MA38096B1/fr unknown
-
2015
- 2015-04-17 PH PH12015500850A patent/PH12015500850B1/en unknown
- 2015-04-21 ZA ZA2015/02684A patent/ZA201502684B/en unknown
- 2015-04-21 CU CUP2015000037A patent/CU20150037A7/es unknown
- 2015-04-24 CL CL2015001078A patent/CL2015001078A1/es unknown
- 2015-05-06 CR CR20150233A patent/CR20150233A/es unknown
- 2015-05-26 US US14/721,151 patent/US9486406B2/en active Active
-
2016
- 2016-08-24 JP JP2016163544A patent/JP6282699B2/ja active Active
- 2016-09-28 US US15/278,514 patent/US9855246B2/en active Active
- 2016-10-24 JP JP2016208082A patent/JP2017014294A/ja active Pending
-
2017
- 2017-11-27 US US15/823,282 patent/US20180085349A1/en not_active Abandoned
-
2018
- 2018-01-11 JP JP2018002514A patent/JP2018058905A/ja not_active Withdrawn
-
2019
- 2019-02-28 JP JP2019036146A patent/JP2019081798A/ja not_active Withdrawn
-
2020
- 2020-06-17 JP JP2020104619A patent/JP2020147606A/ja not_active Withdrawn
-
2021
- 2021-07-13 CY CY20211100633T patent/CY1124481T1/el unknown
- 2021-12-16 US US17/552,872 patent/US12133842B2/en active Active
-
2023
- 2023-01-31 JP JP2023012804A patent/JP2023041804A/ja not_active Withdrawn
-
2024
- 2024-10-10 US US18/912,202 patent/US20250032452A1/en active Pending
- 2024-11-29 JP JP2024207997A patent/JP2025019330A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016196511A5 (enExample) | ||
| CO7111300A2 (es) | Formulación de anticuerpos | |
| PH12017500844B1 (en) | Stable protein solution formulation containing high concentration of an anti-vegf antibody | |
| JP2015078230A5 (enExample) | ||
| EA201200096A1 (ru) | Фармацевтическая композиция ингибитора протеазы вируса гепатита c | |
| EA201491285A1 (ru) | Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты | |
| EA201490801A1 (ru) | Композиции этанерцепта, стабилизированные комбинациями сахаров и полиолов | |
| SI2648520T1 (en) | Formulation of dexmedetomidine pre-mixtures | |
| BR112014026493A2 (pt) | derivados de imidazotiadiazol como inibidores do receptor ativado por protease 4 (par4) para tratar a agregação de plaqueta | |
| FI3511004T3 (fi) | Yhdistelmävalmisteita syövän hoitoon | |
| EA201691490A1 (ru) | Фармацевтическая композиция, содержащая бринзоламид | |
| CL2021001636A1 (es) | Composición farmacéutica para el tratamiento de la hipertensión arterial pulmonar | |
| MX385518B (es) | FORMULACIÓN QUE TIENE CARACTERÍSTICAS MEJORADAS DE LIBERACIÓN DE FÁRMACOS pH DEPENDIENTES, QUE CONTIENEN ESOMEPRAZOL O UNA DE SUS SALES FARMACÉUTICAS ACEPTABLE. | |
| PE20191550A1 (es) | COMPOSICION FARMACEUTICA ACUOSA DE ANTICUERPO MONOCLONAL ANTI-TNFalfa RECOMBINANTE | |
| AR095538A1 (es) | Composiciones farmacéuticas de ésteres de testosterona de cadena larga lipoequilibrados para la administración oral | |
| MX387263B (es) | Composición farmacéutica de liberación prolongada que comprende cisteamina o sal de la misma. | |
| EA201791458A1 (ru) | Фармацевтическая композиция для лечения заболеваний желудочно-кишечного тракта | |
| BR112014017058A8 (pt) | formulações farmacêuticas estabilizadas de um potente inibidor de hcv | |
| EA201691763A1 (ru) | Стабильная быстрорастворимая лекарственная форма, содержащая амоксициллин и клавулановую кислоту | |
| JP6854710B2 (ja) | ペメトレキセドを含有する注射用溶液製剤 | |
| AR130115A2 (es) | Formulación de solución de proteína estable que contiene alta concentración de un anticuerpo anti-vegf | |
| CY1124893T1 (el) | Φαρμακευτικο μeιγμα μαροπιταντης | |
| AR102572A1 (es) | Formulación de solución de proteína estable que contiene alta concentración de un anticuerpo anti-vegf | |
| MX383557B (es) | Formulaciones inyectables de paracetamol. | |
| AR115293A1 (es) | Composición farmacéutica para el tratamiento de la hipertensión arterial pulmonar |